Lyra Therapeutics (LYRA) Return on Capital Employed (2020 - 2025)

Quarterly Return on Capital Employed rose 5870.0% to 102.09% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 102.09% through Dec 2025, up 5870.0% year-over-year, with the annual reading at 74.38% for FY2025, 3052.0% up from the prior year.

Lyra Therapeutics' Return on Capital Employed history spans 6 years, with the latest figure at 102.09% for Q4 2025.

  • Return on Capital Employed came in at 102.09% for Q4 2025, down from 91.34% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 35.48% in Q1 2021 to a low of 163.79% in Q1 2025.
  • The 5-year median for Return on Capital Employed is 69.26% (2021), against an average of 88.44%.
  • Year-over-year, Return on Capital Employed tumbled -12824bps in 2022 and then skyrocketed 9342bps in 2023.
  • Lyra Therapeutics' Return on Capital Employed stood at 101.27% in 2021, then soared by 45bps to 56.17% in 2022, then dropped by -7bps to 59.93% in 2023, then tumbled by -168bps to 160.79% in 2024, then surged by 37bps to 102.09% in 2025.
  • Per Business Quant, the three most recent readings for LYRA's Return on Capital Employed are 102.09% (Q4 2025), 91.34% (Q3 2025), and 95.92% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 450.31%
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 51.73%
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -107.40%
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 21.10%
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 10.19%
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 20.34%
10 Lyra Therapeutics - - - -102.09%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -102.09%
Sep 30, 2025 -91.34%
Jun 30, 2025 -95.92%
Mar 31, 2025 -163.79%
Dec 31, 2024 -160.79%
Sep 30, 2024 -141.42%
Jun 30, 2024 -107.11%
Mar 31, 2024 -59.45%
Dec 31, 2023 -59.93%
Sep 30, 2023 -63.33%
Jun 30, 2023 -66.69%
Mar 31, 2023 -70.30%
Dec 31, 2022 -56.17%
Sep 30, 2022 -49.30%
Jun 30, 2022 -65.37%
Mar 31, 2022 -163.72%
Dec 31, 2021 -101.27%
Sep 30, 2021 -68.23%
Jun 30, 2021 -47.02%
Mar 31, 2021 -35.48%
Dec 31, 2020 -28.04%
Sep 30, 2020 -22.91%
Jun 30, 2020 -27.72%
Mar 31, 2020 -75.50%